Although millions of patients now have new hope because to advancements in targeted therapy, cancer remains one of the world's top causes of death. One such life-saving drug is gefitinib, which is mostly used to treat non-small cell lung cancer (NSCLC), one of the several forms of lung cancer. This medication targets cancer cells directly while causing the least amount of harm to healthy...